Skip to content

Author

Shi-Peng Ning

We have 3 of 44 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Electrochemical Valence‐Regulated Biomimetic Nanozymes for Breast Cancer Metabolism Inhibition and Potentiated Catalytic Immunotherapy

ABSTRACT Manganese oxide (MnOx) nanozymes have garnered significant attention for their ability to respond to the tumor microenvironment (TME) and stimulator of interferon genes (STING) pathway activation. However, they often suffer from a weak direct tumor‐killing capacity due to low enzymatic activity and from attenu...

You Pan, Wei Cai, Meng Suo et al. · 0 citations
Open access Sep 2026

Organic Nanozyme‐Embedded Biotherapeutic Thermosensitive Hydrogel for Extracellular GSH Depletion and Postoperative Tumor Suppression

ABSTRACT Postoperative tumor recurrence remains a major challenge in solid tumor treatment, largely attributed to an immunosuppressive tumor microenvironment and the enrichment of extracellular glutathione (GSH) in the tumor bed, which supports tumor cell survival and proliferation. To address these issues, we designed...

Cong Jiang, Zi-Fan Yang, Rong Guo et al. · 0 citations
Review Open access Jul 2026

Personalized cancer vaccines: bridging immune-oncology and precision medicine for advanced therapeutics

Next-generation personalized cancer vaccines are advancing the transition from reactive treatment to proactive, precision-controlled cancer immunotherapy, and when integrated with artificial intelligence for antigen selection and multiomics for patient stratification, these platforms accelerate vaccine design and impro...

L. Ye, GuoWei Zhao, Jiaxiu Ma et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.